Published in Urology on June 01, 1998
Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res (2009) 1.18
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL. J Cell Mol Med (2011) 1.13
p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets? Cancer (2010) 1.00
Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients. Br J Cancer (2004) 0.99
Clear cell adenocarcinoma of the colon: a case report and review of literature. World J Gastroenterol (2008) 0.93
Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J Korean Med Sci (2005) 0.88
Molecular and immunologic markers of kidney cancer-potential applications in predictive, preventive and personalized medicine. EPMA J (2015) 0.80
Heat shock protein expression in adenosine triphosphate depleted renal epithelial cells. Korean J Intern Med (2004) 0.77
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma. Oncotarget (2016) 0.75
Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway. Mol Med Rep (2015) 0.75
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell (1990) 7.12
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol (2001) 6.19
Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol (2000) 4.72
Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A (1994) 4.53
ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res (2001) 4.47
A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci U S A (1997) 3.88
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis (2003) 3.73
Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol (2001) 3.65
Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J (1992) 3.65
Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell (1978) 3.53
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A (2000) 3.51
Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology (1999) 3.44
Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J (1997) 3.34
Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol (2001) 2.85
NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol Cell Biol (2000) 2.71
Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J (1998) 2.68
Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene. EMBO J (1988) 2.66
Collagen fibril formation. Optimal in vitro conditions and preliminary kinetic results. J Biol Chem (1978) 2.65
Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol (1991) 2.55
Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol (1999) 2.25
Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc Natl Acad Sci U S A (1992) 2.20
Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J (2000) 2.11
p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J (1999) 2.07
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature (1979) 2.01
The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J (2000) 1.98
Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. J Urol (1997) 1.89
Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol (2000) 1.83
Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J Biol Chem (1997) 1.77
Collagen fibril formation. Evidence for a multistep process. J Biol Chem (1979) 1.77
Renal cryosurgery: experimental evaluation of treatment parameters. Urology (1998) 1.76
The psychosocial impact of donating a kidney: long-term follow-up from a urology based center. J Urol (1997) 1.76
Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science (1994) 1.72
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis (1986) 1.72
The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc Natl Acad Sci U S A (1995) 1.70
DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J Biol Chem (1999) 1.70
A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J (2000) 1.68
Pheochromocytoma coexisting with renal artery lesions. J Urol (2000) 1.67
Strategies for transplantation of cadaveric kidneys with congenital fusion anomalies. J Urol (2001) 1.65
Potential Alu function: regulation of the activity of double-stranded RNA-activated kinase PKR. Mol Cell Biol (1998) 1.64
HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology (1994) 1.63
Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure. EMBO J (1985) 1.59
HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology (1995) 1.56
Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells. Eur J Biochem (1978) 1.54
Retroperitoneal laparoscopic radical nephrectomy: the Cleveland clinic experience. J Urol (2000) 1.52
Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR. J Biol Chem (1995) 1.50
Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest (1997) 1.48
Renal outcome 25 years after donor nephrectomy. J Urol (2001) 1.47
The current level of involvement of urological trainees and faculty in clinical kidney transplantation in the United States and Canada. J Urol (1997) 1.46
Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J Interferon Res (1989) 1.45
Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience. J Urol (2000) 1.42
The respective roles of the protein kinase and pppA2' p5' A2' p5 A-activated endonuclease in the inhibition of protein synthesis by double stranded RNA in rabbit reticulocyte lysates. Nucleic Acids Res (1979) 1.42
Laparoscopic radical nephrectomy in 100 patients: a single center experience from the United States. Cancer (2001) 1.39
The role of WT1 in Wilms tumorigenesis. FASEB J (1993) 1.37
Transcriptional regulation of interferon-responsive genes is closely linked to interferon receptor occupancy. EMBO J (1986) 1.36
Needlescopic adrenalectomy--the initial series: comparison with conventional laparoscopic adrenalectomy. Urology (1998) 1.36
Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum Mol Genet (1993) 1.36
The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol Cell Biol (2000) 1.35
Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells. Nature (1978) 1.35
Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J Biol Chem (1998) 1.34
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem (1987) 1.34
Thoracoscopic transdiaphragmatic adrenalectomy: the initial experience. J Urol (2001) 1.33
RFLP detected by an X-linked cDNA encoding erythroid-potentiating activity/tissue inhibitor of metalloproteinase (EPA/TIMP). Nucleic Acids Res (1986) 1.33
The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am (1984) 1.31
Roles of protein-tyrosine phosphatases in Stat1 alpha-mediated cell signaling. J Biol Chem (1995) 1.30
Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science (1990) 1.29
The use of single pediatric cadaver kidneys for transplantation. Transplantation (1988) 1.29
Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science (1990) 1.28
RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J Immunol (2001) 1.27
Perforation of the colon in renal homograft recipients. A report of 11 cases and a review of the literature. Ann Surg (1986) 1.26
Renal hypothermia: in vivo and ex vivo. Urol Clin North Am (1983) 1.26
Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum Mol Genet (1998) 1.25
Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol (1998) 1.24
Complications of nephron sparing surgery for renal tumors. J Urol (1994) 1.24
Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology (2001) 1.23
Laparoscopic radical cystoprostatectomy with ileal conduit performed completely intracorporeally: the initial 2 cases. Urology (2000) 1.23
Signal transduction in the interferon system. Semin Oncol (1998) 1.23
Successful outcomes in pheochromocytoma surgery in the modern era. J Urol (1999) 1.23
Renal cell carcinoma with inferior vena cava tumor thrombi. Surg Gynecol Obstet (1991) 1.22
Experience with extra-adrenal pheochromocytoma. J Urol (1989) 1.20
Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma. Urology (1999) 1.20
Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol (1999) 1.19
Laparoscopic adrenalectomy: the preferred choice? A comparison to open adrenalectomy. J Urol (1998) 1.18
Signal transduction by interferon-alpha through arachidonic acid metabolism. Science (1991) 1.17
Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation (1996) 1.16
Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium. J Urol (1996) 1.16
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol (1999) 1.15
Pericarditis following renal transplantation. Transplantation (1991) 1.15
Molecular cloning of partial cDNA copies of two distinct mouse IFN-beta mRNAs. Nucleic Acids Res (1982) 1.14
The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucleic Acids Res (1991) 1.14
Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol (1995) 1.13
Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology (1995) 1.13
Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J Interferon Cytokine Res (2000) 1.13
Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol (1994) 1.11
T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. J Immunol (1999) 1.11
The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells. Virology (1993) 1.10